Cargando…

Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid

BACKGROUND: The AT(N) classification was proposed for categorising individuals according to biomarkers. However, AT(N) profiles may vary depending on the markers chosen and the target population. METHODS: We stratified 177 individuals who participated in the Japanese Alzheimer’s Disease Neuroimaging...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasuga, Kensaku, Kikuchi, Masataka, Tsukie, Tamao, Suzuki, Kazushi, Ihara, Ryoko, Iwata, Atsushi, Hara, Norikazu, Miyashita, Akinori, Kuwano, Ryozo, Iwatsubo, Takeshi, Ikeuchi, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379489/ https://www.ncbi.nlm.nih.gov/pubmed/36046332 http://dx.doi.org/10.1136/bmjno-2022-000321

Ejemplares similares

Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17
por: Kasuga, Kensaku, et al.
Publicado: (2015)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease
por: Hara, Norikazu, et al.
Publicado: (2017)

Evidence for a Common Founder and Clinical Characteristics of Japanese Families with the MAPT R406W Mutation
por: Ikeuchi, Takeshi, et al.
Publicado: (2011)

Enhancer variants associated with Alzheimer’s disease affect gene expression via chromatin looping
por: Kikuchi, Masataka, et al.
Publicado: (2019)

Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Iwata, Atsushi, et al.
Publicado: (2018)

Disruption of a RAC1-centred network is associated with Alzheimer’s disease pathology and causes age-dependent neurodegeneration
por: Kikuchi, Masataka, et al.
Publicado: (2020)

Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis
por: Sato, Kenichiro, et al.
Publicado: (2019)

Genetics of Alzheimer’s disease: an East Asian perspective
por: Miyashita, Akinori, et al.
Publicado: (2022)

Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease
por: Suzuki, Kazushi, et al.
Publicado: (2020)

Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study
por: Sato, Kenichiro, et al.
Publicado: (2021)

Biallelic COX10 Mutations and PMP22 Deletion in a Family With Leigh Syndrome and Hereditary Neuropathy With Liability to Pressure Palsy
por: Kuroha, Yasuko, et al.
Publicado: (2022)

Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Yagi, Takuya, et al.
Publicado: (2019)

Switched Aβ43 generation in familial Alzheimer’s disease with presenilin 1 mutation
por: Kakuda, Nobuto, et al.
Publicado: (2021)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

Attempt to Predict A/T/N-Based Alzheimer’s Disease Cerebrospinal Fluid Biomarkers Using a Peripheral Blood DNA Methylation Clock
por: Sato, Kenichiro, et al.
Publicado: (2020)

Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease
por: Sato, Yoshiaki, et al.
Publicado: (2015)

The past, present, and future of disease-modifying therapies for Alzheimer’s disease
por: SUZUKI, Kazushi, et al.
Publicado: (2017)

Sample Size Estimation for Alzheimer’s Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging
por: Fujishima, Motonobu, et al.
Publicado: (2017)

Longitudinal clinical and neuro-radiological findings in a patient with leukoencephalopathy with brain calcifications and cysts (Labrune syndrome)()
por: Iwasaki, Yasushi, et al.
Publicado: (2017)

Identification of Unstable Network Modules Reveals Disease Modules Associated with the Progression of Alzheimer’s Disease
por: Kikuchi, Masataka, et al.
Publicado: (2013)

Identification of mild cognitive impairment subtypes predicting conversion to Alzheimer’s disease using multimodal data
por: Kikuchi, Masataka, et al.
Publicado: (2022)

Effects of an essential amino acid mixture on behavioral and psychological symptoms of dementia and executive function in patients with Alzheimer's disease: A double‐blind, randomized, placebo‐controlled exploratory clinical trial
por: Takada, Michihiro, et al.
Publicado: (2022)

Novel CHP1 mutation in autosomal-recessive cerebellar ataxia: autopsy features of two siblings
por: Saito, Rie, et al.
Publicado: (2020)

A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review
por: Hosaka, Takashi, et al.
Publicado: (2017)

Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease
por: Miyashita, A, et al.
Publicado: (2014)

A Patient with Fragile X-Associated Tremor/Ataxia Syndrome Presenting with Executive Cognitive Deficits and Cerebral White Matter Lesions
por: Kasuga, Kensaku, et al.
Publicado: (2011)

Alterations in Glycerolipid and Fatty Acid Metabolic Pathways in Alzheimer's Disease Identified by Urinary Metabolic Profiling: A Pilot Study
por: Watanabe, Yumi, et al.
Publicado: (2021)

A functional variant of SHARPIN confers increased risk of late-onset Alzheimer’s disease
por: Asanomi, Yuya, et al.
Publicado: (2021)

Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial‐Ready Cohort study
por: Sato, Kenichiro, et al.
Publicado: (2021)

Neurofilament light chain for classifying the aetiology of alteration of consciousness
por: Ongphichetmetha, Tatchaporn, et al.
Publicado: (2023)

AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease
por: Mizuno, Satoshi, et al.
Publicado: (2012)

A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer’s disease
por: Asanomi, Yuya, et al.
Publicado: (2019)

Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
por: Murakami, Hidetomo, et al.
Publicado: (2019)

Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy
por: Mori, Yukiko, et al.
Publicado: (2021)

Oculopharyngodistal myopathy with coexisting histology of systemic neuronal intranuclear inclusion disease: Clinicopathologic features of an autopsied patient harboring CGG repeat expansions in LRP12
por: Saito, Rie, et al.
Publicado: (2020)

Possibility for Prevention of Type 2 Diabetes Mellitus and Dementia Using Three Kinds of Brown Rice Blends after High-Pressure Treatment
por: Nakamura, Sumiko, et al.
Publicado: (2022)

Molecular Network Analysis of the Urinary Proteome of Alzheimer's Disease Patients
por: Watanabe, Yumi, et al.
Publicado: (2019)

Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease
por: Watanabe, Yumi, et al.
Publicado: (2020)

Elevated C-Reactive Protein Is Associated with Cognitive Decline in Outpatients of a General Hospital: The Project in Sado for Total Health (PROST)
por: Watanabe, Yumi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_thor7k6rs8bs6b6fi2h4gi99tu